HORIZON THERAPEUTICS PUB L's ticker is HZNP and the CUSIP is G46188101. A total of 564 filers reported holding HORIZON THERAPEUTICS PUB L in Q3 2021. The put-call ratio across all filers is 0.33 and the average weighting 0.4%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2022 | $1,300,000 | -20.5% | 21,010 | +2.4% | 0.15% | -15.6% |
| Q2 2022 | $1,636,000 | -20.7% | 20,510 | +4.6% | 0.17% | -13.1% |
| Q1 2022 | $2,063,000 | -0.5% | 19,609 | +1.9% | 0.20% | +7.6% |
| Q4 2021 | $2,073,000 | -33.3% | 19,240 | -32.2% | 0.18% | -41.8% |
| Q3 2021 | $3,109,000 | +23.5% | 28,378 | +5.6% | 0.32% | +28.7% |
| Q2 2021 | $2,517,000 | +7.2% | 26,884 | +5.4% | 0.25% | 0.0% |
| Q1 2021 | $2,347,000 | +32.2% | 25,499 | +5.0% | 0.25% | +22.3% |
| Q4 2020 | $1,776,000 | +1.8% | 24,279 | +8.2% | 0.20% | -9.8% |
| Q3 2020 | $1,744,000 | -0.2% | 22,445 | -28.6% | 0.22% | -6.7% |
| Q2 2020 | $1,748,000 | +89.6% | 31,451 | +1.0% | 0.24% | +51.9% |
| Q1 2020 | $922,000 | -22.5% | 31,140 | -5.3% | 0.16% | -1.9% |
| Q4 2019 | $1,190,000 | +33.9% | 32,879 | +0.7% | 0.16% | +26.8% |
| Q3 2019 | $889,000 | +12.2% | 32,655 | -0.8% | 0.13% | +9.5% |
| Q2 2019 | $792,000 | – | 32,902 | – | 0.12% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Kopp Family Office, LLC | 544,835 | $57,322,000 | 30.98% |
| Paulson & Co. | 5,614,000 | $590,649,000 | 18.18% |
| Avoro Capital Advisors LLC | 6,500,000 | $683,865,000 | 12.48% |
| 1492 Capital Management LLC | 121,840 | $12,819,000 | 6.80% |
| Iron Triangle Partners LP | 503,744 | $52,999,000 | 6.30% |
| Tri Locum Partners LP | 132,332 | $13,923,000 | 5.44% |
| HealthCor Management, L.P. | 710,110 | $74,711,000 | 4.98% |
| Eversept Partners, LP | 609,939 | $64,171,682 | 4.93% |
| Bain Capital Public Equity Management II, LLC | 1,286,371 | $135,339,000 | 4.33% |
| PFM Health Sciences, LP | 1,091,840 | $114,872,000 | 4.30% |